ALFENTANIL PHARMACOKINETICS IN PRETERM INFANTS

被引:39
作者
MARLOW, N
WEINDLING, AM
VANPEER, A
HEYKANTS, J
机构
[1] JANSSEN PHARMACEUT, B-2340 BEERSE, BELGIUM
[2] LIVERPOOL MATERN HOSP, DEPT CHILD HLTH, LIVERPOOL, ENGLAND
来源
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION | 1990年 / 65卷 / 04期
关键词
D O I
10.1136/adc.65.4_Spec_No.349
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The pharmacokinetics of alfentanil were studied during the first four days after birth in 22 ventilated preterm infants who were all receiving muscle relaxants. Five minutes after a single dose of 20 μg/kg alfentanil median serum concentration was 66 ng/ml (range: 20-606). The median clearance ws 0·87 ml/kg/min (range: 0·4-9·62) and median elimination half life 321 mins (64-1251). There were wide differences in the manner in which individual infants handled the drug and transient depression of blood pressure and heart rate was observed. These data were used to calculate an infusion dosage. In four infants 20 μg/kg alfentanil given by infusion over 30 minutes followed by 5 μg/kg/hour produced steady state median alfentanil concentrations of 54·5 ng/ml (range: 7-73 ng/ml) with no evidence of drug accumulation.
引用
收藏
页码:349 / 351
页数:3
相关论文
共 50 条
  • [21] Oral pharmacokinetics of doxapram in preterm infants.
    de Wildt, SN
    Sie, SD
    Dullemond, RC
    Vulto, AP
    van den Anker, JN
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P68 - P68
  • [22] VANCOMYCIN PHARMACOKINETICS AND DOSE RECOMMENDATIONS FOR PRETERM INFANTS
    JAMES, A
    KOREN, G
    MILLIKEN, J
    SOLDIN, S
    PROBER, CG
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1986, 9 (03): : A89 - A89
  • [23] MATURATIONAL CHANGES OF THEOPHYLLINE PHARMACOKINETICS IN PRETERM INFANTS
    DOTHEY, CI
    TSERNG, KY
    KAW, S
    KING, KC
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (05) : 461 - 468
  • [24] VANCOMYCIN PHARMACOKINETICS AND DOSE RECOMMENDATIONS FOR PRETERM INFANTS
    JAMES, A
    KOREN, G
    MILLIKEN, J
    SOLDIN, S
    PROBER, C
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (01) : 52 - 54
  • [25] Clindamycin Pharmacokinetics and Safety in Preterm and Term Infants
    Gonzalez, Daniel
    Delmore, Paula
    Bloom, Barry T.
    Cotten, C. Michael
    Poindexter, Brenda B.
    McGowan, Elisabeth
    Shattuck, Karen
    Bradford, Kathleen K.
    Smith, P. Brian
    Cohen-Wolkowiez, Michael
    Morris, Maurine
    Yin, Wanrong
    Benjamin, Daniel K., Jr.
    Laughon, Matthew M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (05) : 2888 - 2894
  • [26] Population Pharmacokinetics of Nirsevimab in Preterm and Term Infants
    Clegg, Lindsay
    Freshwater, Ed
    Leach, Amanda
    Villafana, Tonya
    Hamren, Ulrika Waehlby
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (05) : 555 - 567
  • [27] PHARMACOKINETICS OF HUMAN RECOMBINANT ERYTHROPOIETIN IN PRETERM INFANTS
    BROWN, MS
    JONES, MA
    OHLS, RK
    CHRISTENSEN, RD
    CLINICAL RESEARCH, 1993, 41 (01): : A22 - A22
  • [28] THE PHARMACOKINETICS OF ALFENTANIL IN MAN
    HULL, CJ
    BRITISH JOURNAL OF ANAESTHESIA, 1983, 55 : S157 - S164
  • [29] THE PHARMACOKINETICS OF ALFENTANIL IN CHILDREN
    GORESKY, GV
    KOREN, G
    SABOURIN, MA
    SALE, JP
    STRUNIN, L
    ANESTHESIOLOGY, 1987, 67 (05) : 654 - 659
  • [30] PHARMACOKINETICS OF ALFENTANIL IN MAN
    CAMU, F
    GEPTS, E
    RUCQUOI, M
    HEYKANTS, J
    ANESTHESIA AND ANALGESIA, 1982, 61 (08) : 657 - 661